Federal Bid

Last Updated on 08 Sep 2021 at 7 PM
Solicitation
Bethesda Maryland

Role of Cdk5 in neurodevelopment and neurodegeneration

Solicitation ID 75N95021Q00356
Posted Date 08 Sep 2021 at 7 PM
Archive Date 28 Sep 2021 at 4 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office National Institutes Of Health Nida
Agency Department Of Health And Human Services
Location Bethesda Maryland United states 20892

This acquisition shall consist of the following items:
Line 1 - ARRAY, DROGENE-1.0-ST, 6PK EACH, SKU#: 902155. Quantity: 2.
Line 2 - GENECHIP WT PLUS REAGENT KIT 30 RXN, SKU#: 902281. Quantity: 2.
Line 3 - KIT, DROGENE-1.0-ST ARRAY 30PK, SKU#: 902156. Quantity: 3.

(vi) The National Institute of Neurological Disorders and Stroke (NINDS) requires a set of oligonucleotide microarrays that allow accurate measurement of the expression levels of all the exons of all the genes in the Drosophilia genome. This is known as “expression profiling”. A large number of these arrays are required to measure expression level in both normal and mutant animals, at multiple ages, separately for the head and the body, and to do enough repeats for appropriate statistical analysis. Use of these chips will allow the NINDS to separate how a neurodegenerative mutation accelerates aging from how it causes death. NINDS participates in a trans-NIH Institute & Center shared resource for microarray experiments. For analysis of gene expression in Drosophila, the hardware, software and technical expertise available in the Microarray Facility are only compatible with the microarrays fabricated by the company Affymetrix. The salient characteristics for this requirement described in Attachment 1 – Purchase Description and shall include:
- The Affymetrix Drosophila GeneChip 1.0 ST can be used to assay expression of all the genes in the Drosophila genome.
- This chip is based on a recent annotation of the Drosophila genome, which corrects
previous errors and includes genes that were not identified previously.
- The 1.0 ST GeneChip uses a proprietary technology that allows assay of the entirety of each gene, rather than being weighted toward gene 3’ ends. This gives greater accuracy, and also allows separate detection and quantification of multiple splice variants rather than binning them together in uncontrolled ways that lose information and increase experimental noise.
- Use of this GeneChip allows accurate statistical comparison of our data to our previous results, and to results in the published literature.

Bid Protests Not Available

Similar Past Bids

Bethesda Maryland 19 Aug 2021 at 3 PM
Bayview Idaho 18 Jun 2019 at 9 PM
Gaithersburg Maryland 20 May 2020 at 5 PM
Location Unknown 17 Mar 2021 at 4 AM

Similar Opportunities

Range Alabama 11 Jul 2025 at 9 PM
Annville Pennsylvania 16 Jul 2025 at 12 PM
Hill air force base Utah 11 Jul 2025 at 8 PM
Hill air force base Utah 11 Jul 2025 at 8 PM